Literature DB >> 30762167

Maternal germline mosaicism in Fabry disease.

Luigi Pianese1, Antonio Fortunato2, Serena Silvestri2, Francesco G Solano3, Alberto Burlina4, Alessandro P Burlina5, Michele Ragno6.   

Abstract

Fabry disease (FD) is an X-linked monogenic disorder caused by mutations in the GLA gene which leads to a deficiency of the functionally active lysosomal α-galactosidase A enzyme. Here, we report on a family of five members: unaffected parents, one unaffected son, and another son and daughter both carrying the same mutation (p.G138E) in the GLA gene. Genotype analysis using intragenic GLA markers confirmed the maternal origin of the mutation. The affected son and daughter carried the same mutation; however, it was not detected in the peripheral blood, buccal cells, and urinary sediment cells of their mother. Moreover, the unaffected son without the alteration in the GLA gene carried the same maternal chromosome X (disease-associated) haplotype. To the best of our knowledge, this study represents the first case of maternal germline mosaicism in FD.

Entities:  

Keywords:  Fabry disease; GLA; Germline mosaicism; Mutation

Mesh:

Substances:

Year:  2019        PMID: 30762167     DOI: 10.1007/s10072-019-03754-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

1.  Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene.

Authors:  L Ferri; C Guido; G la Marca; S Malvagia; C Cavicchi; A Fiumara; R Barone; R Parini; D Antuzzi; C Feliciani; A Zampetti; R Manna; S Giglio; C M Della Valle; X Wu; K J Valenzano; R Benjamin; M A Donati; R Guerrini; M Genuardi; A Morrone
Journal:  Clin Genet       Date:  2011-05-25       Impact factor: 4.438

2.  Recurrence of Fabry disease as a result of paternal germline mosaicism for alpha-galactosidase a gene mutation.

Authors:  Robert Dobrovolný; Lenka Dvoráková; Jana Ledvinová; Sudheera Magage; Jan Bultas; Jean C Lubanda; Helena Poupetová; Milan Elleder; Debora Karetová; Martin Hrebícek
Journal:  Am J Med Genet A       Date:  2005-04-01       Impact factor: 2.802

3.  Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group.

Authors:  Andreas Gal; Derralynn A Hughes; Bryan Winchester
Journal:  J Inherit Metab Dis       Date:  2011-01-13       Impact factor: 4.982

4.  X-chromosome inactivation in female patients with Fabry disease.

Authors:  L Echevarria; K Benistan; A Toussaint; O Dubourg; A A Hagege; D Eladari; F Jabbour; C Beldjord; P De Mazancourt; D P Germain
Journal:  Clin Genet       Date:  2015-06-22       Impact factor: 4.438

5.  Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype.

Authors:  Satoshi Ishii; Shoichiro Nakao; Reiko Minamikawa-Tachino; Robert J Desnick; Jian-Qiang Fan
Journal:  Am J Hum Genet       Date:  2002-02-04       Impact factor: 11.025

6.  Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS/MS.

Authors:  Giulia Polo; Alessandro P Burlina; Thilini B Kolamunnage; Michele Zampieri; Carlo Dionisi-Vici; Pietro Strisciuglio; Martina Zaninotto; Mario Plebani; Alberto B Burlina
Journal:  Clin Chem Lab Med       Date:  2017-03-01       Impact factor: 3.694

7.  Fabry disease: twenty novel alpha-galactosidase A mutations and genotype-phenotype correlations in classical and variant phenotypes.

Authors:  Dominique P Germain; Junaid Shabbeer; Sylvie Cotigny; Robert J Desnick
Journal:  Mol Med       Date:  2002-06       Impact factor: 6.354

8.  Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease.

Authors:  Bouwien E Smid; Linda van der Tol; Marieke Biegstraaten; Gabor E Linthorst; Carla E M Hollak; Ben J H M Poorthuis
Journal:  J Med Genet       Date:  2015-01-16       Impact factor: 6.318

Review 9.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

10.  Genetic screening of Fabry patients with EcoTILLING and HRM technology.

Authors:  Caterina Bono; Domenico Nuzzo; Giuseppe Albeggiani; Carmela Zizzo; Daniele Francofonte; Francesco Iemolo; Enzo Sanzaro; Giovanni Duro
Journal:  BMC Res Notes       Date:  2011-09-06
View more
  3 in total

1.  Rare Neurologic Diseases and Neurological Sciences: a report for the celebration of the 2020 Rare Diseases Day.

Authors:  Antonio Federico
Journal:  Neurol Sci       Date:  2020-03       Impact factor: 3.307

Review 2.  Highlights on Genomics Applications for Lysosomal Storage Diseases.

Authors:  Valentina La Cognata; Maria Guarnaccia; Agata Polizzi; Martino Ruggieri; Sebastiano Cavallaro
Journal:  Cells       Date:  2020-08-14       Impact factor: 6.600

3.  Detection of Very Low-Level Somatic Mosaic COL4A5 Splicing Variant in Asymptomatic Female Using Droplet Digital PCR.

Authors:  Haiyue Deng; Yanqin Zhang; Jie Ding; Fang Wang
Journal:  Front Med (Lausanne)       Date:  2022-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.